Approvals/TGA/ENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial

Approved

STANDARD

ENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial

Jazz Pharmaceuticals ANZ Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ad9634ff007a58a2
Product Name: ENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial
Artg Id: 423019
Artg Name: ENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial
Sponsor: Jazz Pharmaceuticals ANZ Pty Ltd
Company Detail Path: /organization/jazz-pharmaceuticals-anz-pty-ltd
Artg Date: 2025-04-16
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9efd20b19b4912e3c64bd6ae47e1e559.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6c8a95597d6ec6ca31240b9623ebe53b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

ad9634ff007a58a2

Type

Standard